Bilirubin and UGT1A1*28 are not associated with lower risk for ischemic stroke in a prospective nested case-referent setting

Cerebrovascular Diseases

Volumn 30, Issue 6, 2010, Pages 590-596

  Ekblom, Kim ^a,c   Marklund, Stefan L ^a   Johansson, Lars ^b   Osterman, Pia ^a   Hallmans, Göran ^a   Weinehall, Lars ^a   Wiklund, Per Gunnar ^a   Hultdin, Johan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Skelleftea County Hospital   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

Author keywords

Acute ischemic stroke, epidemiology; Bilirubin; Risk factor; UGT1A1*28 polymorphism

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE 1A1; IRON; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BIOLOGICAL MARKER; GLUCURONOSYLTRANSFERASE;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; FEMALE; GENE DOSAGE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RISK REDUCTION; SWEDEN; BLOOD; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STROKE;

BILIRUBIN; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCURONOSYLTRANSFERASE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; SWEDEN;

EID: 77957798191     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319778     Document Type: Article

References (36)

1. Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272:20963-20966.
2. Novotny L, Vitek L: Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 2003;228:568-571.
3. Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y, Gabazza EC, Adachi Y: Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol 2000;35:659-664.
4. Hirschfield GM, Alexander GJ: Gilbert's syndrome: an overview for clinical biochemists. Ann Clin Biochem 2006;43:340-343.
5. Kimm H, Yun JE, Jo J, Jee SH: Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009;40:3422-3427.
6. * 28 allele and coronary heart disease: the Rotterdam Study. Clin Chem 2003;49:1180-1181.
7. * 28 allele is not associated with coronary heart disease: the ECTIM study. Clin Chem 2006;52:2313-2314.
8. *28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006;114:1476-1481.
9. Hallmans G, Agren A, Johansson G, Johansson A, Stegmayr B, Jansson JH, Lindahl B, Rolandsson O, Soderberg S, Nilsson M, Johansson I, Weinehall L: Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scand J Public Health Suppl 2003;61:18-24.
10. Eriksson M, Steg mayr B, Lundberg V: MONICA quality assessments. Scand J Public Health Suppl 2003;61:25-30.
11. Stegmayr B, Lundberg V, Asplund K: The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health Suppl 2003;61:9-17.
12. Johansson L, Jansson JH, Stegmayr B, Nilsson TK, Hallmans G, Boman K: Hemostatic factors as risk markers for intracerebral hemorrhage: a prospective incident case-referent study. Stroke 2004;35:826-830.
13. Ekblom K, Hultdin J, Stegmayr B, Johansson I, Van Guelpen B, Hallmans G, Weinehall L, Johansson L, Wiklund PG, Marklund SL: Iron stores and HFE genotypes are not related to increased risk of ischemic stroke: a prospective nested case-referent study. Cerebrovasc Dis 2007;24:405-411.
14. Van Guelpen B, Hultdin J, Johansson I, Witthoft C, Weinehall L, Eliasson M, Hallmans G, Palmqvist R, Jansson JH, Winkvist A: Plasma folate and total homocysteine levels are associated with the risk of myocardia l infarction, independently of each other and of renal function. J Intern Med 2009;266:182-195.
15. Adegoke OJ, Shu XO, Gao YT, Cai Q, Breyer J, Smith J, Zheng W: Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat 2004;85:239-245. (Pubitemid 38987258)
16. Ishizaka N, Ishizaka Y, Takahashi E, Yamakado M, Hashimoto H: High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke 2001;32:580-583.
17. Vitek L, Novotny L, Sperl M, Holaj R, Spacil J: The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis 2006;21:408-414.
18. Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA: Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med 2008;121:781-788.
19. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, Matsushita T, Yamazaki K, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Sueishi K, Iida M, Nakamura Y, Kiyohara Y: A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 2007;39:212-217.
20. Yamada Y, Fuku N, Tanaka M, Aoyagi Y, Sawabe M, Metoki N, Yoshida H, Satoh K, Kato K, Watanabe S, Nozawa Y, Hasegawa A, Kojima T: Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis 2009;207:144-149.
21. Matarin M, Brown WM, Scholz S, Simon-Sanchez J, Fung HC, Hernandez D, Gibbs JR, De Vrieze FW, Crews C, Britton A, Langefeld CD, Brott TG, Brown RD Jr, Worrall BB, Frankel M, Silliman S, Case LD, Singleton A, Hardy JA, Rich SS, Meschia JF: A genomewide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol 2007;6:414-420.
22. Ikram MA, Seshadri S, Bis JC, Fornage M, De Stefano AL, Aulchenko YS, Debette S, Lumley T, Folsom AR, van den Herik EG, Bos MJ, Beiser A, Cushman M, Launer LJ, Shahar E, Struchalin M, Du Y, Glazer NL, Rosamond WD, Rivadeneira F, Kelly-Hayes M, Lopez OL, Coresh J, Hofman A, De Carli C, Heckbert SR, Koudstaal PJ, Yang Q, Smith NL, Kase CS, Rice K, Haritunians T, Roks G, de Kort PL, Taylor KD, de Lau LM, Oostra BA, Uitterlinden AG, Rotter JI, Boerwinkle E, Psaty BM, Mosley TH, van Duijn CM, Breteler MM, Longstreth WT Jr, Wolf PA: Genomewide association studies of stroke. N Engl J Med 2009;360:1718-1728.
23. Hata J, Matsuda K, Ninomiya T, Yonemoto K, Matsushita T, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Iida M, Kiyohara Y, Nakamura Y, Kubo M: Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Hum Mol Genet 2007;16:630-639.
24. Pruissen DM, Kappelle LJ, Rosendaal FR, Algra A: Genetic association studies in ischaemic stroke: replication failure and prospects. Cerebrovasc Dis 2009;27:290-294.
25. Lanktree MB, Dichgans M, Hegele RA: Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 2010;41:825-832.
26. Maghzal GJ, Leck MC, Collinson E, Li C, Stocker R: Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase. J Biol Chem 2009;284:29251-29259.
27. Yamamoto M, Maeda H, Hirose N, Radhakrishnan G, Katare RG, Hayashi Y, Rao P, Lee GH, Yamaguchi T, Sasaguri S: Bilirubin oxidation provoked by nitric oxide radicals predicts the progression of acute cardiac allograft rejection. Am J Transplant 2007;7:1897-1906.
28. Alizadeh BZ, Njajou OT, Houwing-Duistermaat JJ, de Jong G, Vergeer JM, Hofman A, Pols HA, van Duijn CM: Does bilirubin protect against hemochromatosis gene (HFE) related mortality? Am J Med Genet A 2004;129A:39-43.
29. * 28 are not protective factors against first-time myocardial infarction in a prospective nested casereferent setting. Circ Cardiovasc Genet 2010;3:340-347.
30. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Jian M, Zhou Y, Li Y, Zhang X, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
31. Leung JW, Liu YL, Leung PS, Chan RC, Inciardi JF, Cheng AF: Expression of bacterial beta-glucuronidase in human bile: an in vitro study. Gastrointest Endosc 2001;54:346-350.
32. Fevery J: Bilirubin in clinical practice: a review. Liver Int 2008;28:592-605.
33. Chen YH, Chau LY, Chen JW, Lin SJ: Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care 2008;31:1615-1620.
34. Stocker R, Perrella MA: Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 2006;114:2178-2189.
35. Li C, Hossieny P, Wu BJ, Qawasmeh A, Beck K, Stocker R: Pharmacologic induction of heme oxygenase-1. Antioxid Redox Signal 2007;9:2227-2239.
36. Bock KW, Gschaidmeier H, Heel H, Lehmkoster T, Munzel PA, Bock-Hennig BS: Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases. Drug Metab Rev 1999;31:411-422.